EROAD's (ASX:ERD, NZE:ERD) fiscal 2025 guidance is "disappointing", Jarden Research said in a Nov.25 note.
EROAD reported revenue of NZ$95.9 million for the six months ended Sept. 30, up 8% from its revenue of NZ$ 88.9 million in the same period a year earlier.
For the fiscal year ending June 30, 2025, EROAD expects revenue between NZ$190 million to NZ$195 million, EBIT between NZ$5 million to NZ$10 million, and R&D spending of NZ$35 million, up from NZ$32 million last year.
The company said it was "on track" to meet the guidance.
Jarden believes that the guidance will not let the company achieve the fiscal 2026 revenue CAGR target of over 11% to 13%, which is in line with market growth expectations.
"Maintenance of FY25 guidance is disappointing given the required execution to meet FY26 targets", Jarden added.
The investment firm maintained EROAD's neutral rating but raised its target price to NZ$1.05 from NZ$0.96.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。